<DOC>
	<DOCNO>NCT00865540</DOCNO>
	<brief_summary>The main objective study compare effect preoperative use anti-inflammatory topical prednisolone acetate 1 % , nepafenac 0.1 % ketorolac tromethamine 0.4 % , plus placebo , maintain intra-operative mydriasis extraction .</brief_summary>
	<brief_title>Effect Anti-inflammatory Topical Prednisolone , Nepafenac Ketorolac Intra-operative Mydriasis Facetectomies</brief_title>
	<detailed_description>Will conduct randomized clinical trial volunteer indication extraction Recife , Brazil . The surgical technique employ phacoemulsification implantation intraocular lens . Digital photo take eye begin end surgery digitally determine relationship corneal area pupillary area . Each volunteer draw one four group study ( group 1 , prednisolone acetate 1 % , group 2 , ketorolac tromethamine 0.4 % , 0.1 % nepafenac group 3 group 4 , placebo ) . For volunteer randomly select group prescribe medication presentation eye drop ( Prednisolone acetate 1 % , Pred Fort ® , Allergan ® ; ketorolac tromethamine 0.4 % , incite l ® , Allergan ® ; Nepafenac 0.1 % , Nevanac ® Alcon ® 0.5 % methylcellulose , Fresh Tears ® , Allergan ® ) , 01 drop every 8 hour 48 hour surgery . For volunteer also prescribe gatifloxacin ( Zymar ® ) , 01 drop every 8 hour start 48 hour surgery . Was schedule minimum sample 60 volunteer ( 15 per group ) .</detailed_description>
	<mesh_term>Cataract</mesh_term>
	<mesh_term>Mydriasis</mesh_term>
	<mesh_term>Ketorolac</mesh_term>
	<mesh_term>Ketorolac Tromethamine</mesh_term>
	<mesh_term>Nepafenac</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Anti-Inflammatory Agents</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<criteria>Carriers senile cataract ( &gt; 50 year age ) indication cataract extraction implantation intraocular lens , local anesthesia Diabetic Using systemic antihormonal nonhormonal Using topical ocular medication ( include antiglaucomatous ) Individuals congenital ocular abnormality case intraoperative complication ( hernia trauma iris , posterior capsule rupture zônula prolong phacoemulsification time ≥ 1 minute ) . Volunteers incipient nuclear cataract ( density 1 ) advance ( density 4 ) LOCS II classification ( density nuclear cataract rank 1 4 ( Chalk et al , 1989 )</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>cataract</keyword>
	<keyword>pupillary dilation</keyword>
	<keyword>anti-inflammatory</keyword>
	<keyword>therapeutic use</keyword>
</DOC>